Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma.

Schreck, Karisa C; Allen, Amy N; Wang, Jiawan; Pratilas, Christine A

Schreck, Karisa C; Allen, Amy N; Wang, Jiawan; Pratilas, Christine A.

Afiliación

Schreck KC; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
Allen AN; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Wang J; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pratilas CA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.

Neurooncol Adv ; 2(1): vdaa138, 2020.

Article en En | MEDLINE | ID: mdl-33235998

Palabras clave

MEK inhibitor; MTOR inhibitor; glioblastoma; neurosphere; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google